MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL vs. Gadavist® (gadobutrol)1 The MERIT StudySeidl et al.70-year-old man with metastatic lung carcinoma These are representative images from reference studies; individual results may vary.Reference: 1. Seidl Z,...
MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL vs. Gadavist® (gadobutrol)1 The MERIT Study Seidl et al. 58-year-old woman with metastatic melanoma These are representative images from reference studies; individual results may vary.Reference: 1. Seidl Z,...
MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Omniscan™ (gadodiamide)1 The ENHANCE Study Rowley et al.55-year-old woman with glioblastoma with recurrent disease These are representative images from...
MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Magnevist® (gadopentetate dimeglumine)1 Maravilla et al.51-year-old woman with metastatic lung cancer These are representative images from reference...
MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Dotarem® (gadoterate meglumine)1 Colosimo et al.72-year-old woman with primary cerebral lymphoma These are representative images from reference studies;...
Recent Comments